Clinical Trial Update: Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG [Phase 1]

View source ↗

Summary

A Phase I trial evaluating imatinib (Gleevec) in combination with everolimus (RAD001) and hydroxyurea in patients with recurrent glioblastoma or gliosarcoma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Everolimus (everolimus)
• Gleevec (Imatinib)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Annick Desjardins | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED